Team Finds a Better Way to Engineer Therapeutic Proteins into Antibodies Scripps Research and Rockefeller Scientists Work on Obesity Therapy as Proof-of-Principle
LA JOLLA, CA August 13, 2015 Some proteins exist so fleetingly in the bloodstream that they can't be given effectively as therapies. However, building them into larger proteins, such as antibodies, can make them persist long enough to be useful. Now a team led by scientists at The Scripps Research Institute (TSRI) has devised an improved method for accomplishing this protein-engineering feat.
The new method mimics evolution by generating millions of possible junction segments between the inserted protein and its antibody host, selecting the rare ones that allow the inserted protein to fold and function normally. The technique should speed the development of drug and diagnostic compounds that would not have been possible otherwise including powerful hormone-based therapies.
Unlike prior approaches to this design problem, ours is a selection-based method and it's hard to beat this approach, with its ability to harness the power of very large numbers, said senior investigator Richard A. Lerner, the Lita Annenberg Hazen Professor of Immunochemistry at TSRI.
The technique is general enough so it could have many clinical and scientific applications, for example, determining why proteins fold as they do. It effectively enables you to put a measuring device in the middle of a protein to determine if it's folded properly, Lerner said.
The study, a collaboration between Lerner's laboratory at TSRI, the laboratory of Jeffrey M. Friedman at Rockefeller University and the TSRI groups of Ian A. Wilson and Patrick R. Griffin, was reported on August 13 in the journal Chemistry & Biology.
Making Leptin Last Longer
Lerner's laboratory helped pioneer techniques for generating billions of different antibodies and screening these large antibody libraries to find those that perform a desired function. The new work is an extension of that technology.
In one proof-of-principle demonstration, the team edited the genetic code of a standard human antibody to replace one of its target-grappling elements a structure that normally would bind to a virus, for example with the protein leptin.
First identified by Friedman in 1994 as a satiety hormone that switches off hunger, leptin initially failed as an obesity therapy, as obese people tend to be insensitive to leptin rather than leptin-deficient. However, the hormone has drawn renewed interest in recent years as a possible basis for treating obesity in conjunction with leptin-sensitizing compounds and also diabetes.
Leptin on its own and in an unmodified state isn't ideal as a therapy because it doesn't last long in the bloodstream. The kidneys and other organs clear it very rapidly, said Yingjie Peng, a staff scientist in the Lerner laboratory who was first author of the study with Wenwen Zeng of Friedman's lab at Rockefeller. But it could last much longer if it were part of a larger structure such as an antibody.
The major challenge for Lerner, Peng and their colleagues was to design leptin into an antibody in such a way that it would fold up into a functional structure despite being bound to its host protein at either end.
Designing simple, highly flexible junction segments to join leptin to an antibody could work a recent paper by a group including TSRI's Peter Schultz, Scripps Family Chair Professor of Chemistry, described such a feat.
But Lerner's team reasoned that a selection-based design of these junctions would be a more general approach to making useful protein-in-protein molecules.
The Power of Large Numbers
Using their established techniques for generating large libraries of variant antibodies, the team made nearly 30 million versions of the leptin-in-antibody protein, each version having a different amino-acid sequence for its junction segments.
To find the rare versions that enabled leptin to fold up and function properly, the researchers used a selection system that they had previously developed for finding therapeutic antibodies in large antibody libraries. First they employed viral vectors to insert the leptin-in-antibody DNA into test cells that contain leptin receptors. When one of the resulting leptin-in- antibody proteins successfully activated a leptin receptor in its test cell, the event was signaled by a highly sensitive set of fluorescent beacons.
The cells whose beacon signals rose above a certain threshold were analyzed for the leptin-in-antibody DNA they contained, and this DNA was then inserted into new test cells and so on, for round after round of selection, until the process yielded the leptin-in-antibody protein that did best at activating the leptin receptor.
This selected protein turned out to be several times more potent than leptin in terms of its ability to activate the leptin receptor in cultured cells. In tests in Friedman's laboratory, it had a more than a four-hour bloodstream half-life in mice a big improvement over natural leptin.
As is often the case for antibodies, the leptin-in-antibody protein effectively could not cross from the bloodstream into the brain and thus could not hit all of leptin's neuronal targets and so its effects at reducing eating and weight in mice were less than optimal. But, in principle, antibodies can be modified to enable them to cross the blood-brain barrier more easily, and the team is working on that now.
Broad Applications
To highlight the general applicability of the new method, the researchers also used it to selection-design an antibody that incorporates the growth and reproductive hormone FSH which is structurally very different from leptin. The resulting FSH-in-antibody protein showed activity against the FSH receptor that was virtually the same a
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
02/05/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
01/05/2026
January 5 2026, 18:30 (PST) NBCUniversal's Peacock to Be First Streamer to ...
01/04/2026
January 4 2026, 18:00 (PST) DOLBY AND DOUYIN EMPOWER THE NEXT GENERATON OF CREATORS WITH DOLBY VISION
Douyin Users Can Now Create And Share Videos With Stun...
19/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
19/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
19/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
19/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
19/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
19/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
19/03/2026
How Chris Bolte Builds the Sound of PlayStation Games Chris Bolte '16 is a technical sound designer at Sucker Punch Productions, where he helps create the...
18/03/2026
Newly named chief product officer (CPO), Larissa G rner Meeus will return to Net Insight on May 4.
Larissa G rner Meeus will become CPO of Net Insight on May 4...
18/03/2026
SVG Europe's The Football Summit 2026 explored how the sports broadcasting i...
18/03/2026
The 2026 NAB Show kicks off one month from today and SVG is once again set to cover the show from every angle. SVG's SportsTech@NAB Show Blog is now live - ...
18/03/2026
(L-R) The cast and crew of Dead Lover at The Ray Theater for its premiere at the 2025 Sundance Film Festival. (Photo by Robin Marshall/Shutterstock for Sundan...
18/03/2026
Yamaha C7 captured in Nashville
Wiltone Productions have announced the release of Music Row Piano, a deeply sampled Yamaha C7 piano library that's been ...
18/03/2026
Bass-enhancement plug-in upgraded
Along with a steady stream of new releases, Techivation have recently been revisiting some of the older plug-ins in their ...
18/03/2026
Mix-reference plug-in overhauled
iZotope's powerful mix-referencing plug-in has just reached its third major version, and now boasts a new capture proce...
18/03/2026
Latest EZKeys 2 expansion arrives
Toontrack's staggering collection of EZKeys 2 expansions has grown once again, and the latest instalment delivers a on...
18/03/2026
Jess Ho explores the politics of food in new SBS Audio podcast For The Culture
18 March, 2026
Media releases
New SBS Audio podcast For The Culture, hosted ...
18/03/2026
Future-ready broadcasts with ATSC 3.0 and enhanced services from Rohde & Schwarz...
18/03/2026
London Calling - When The Industry Convened to Help Streaming Find its MoJo In this blog, Laura Rognoni reflects on key discussions from the Connected TV World...
18/03/2026
SMPTE Unveils 2026 NAB Show Educational Presentations
Brie Clayton March 18, 2026
0 Comments
SMPTE , the home of media professionals, technologists, a...
18/03/2026
Auditel Ad Campaign Shot on Blackmagic PYXIS 12K
Brie Clayton March 18, 2026
0 Comments
LED wall virtual production blends 12K open gate acquisition w...
18/03/2026
Brainstorm transforms productivity and sustainability with Suite 7 at NAB Show 2...
18/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
18/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
18/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
18/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
18/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
18/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
18/03/2026
SMPTE , the home of media professionals, technologists, and engineers, today unveiled its educational presentations for the 2026 NAB Show. This year SMPTE will ...
18/03/2026
Maxon, maker of powerful, approachable software solutions for creators working in 2D and 3D design, motion graphics, visual effects, gaming, and more, today ann...
18/03/2026
Digital Alert Systems
Preview
2026 NAB Show
April 19 - 22
Booth C3452
At the 2026 NAB Show, Digital Alert Systems will showcase Version 6.0 of its DASDEC ...
18/03/2026
Setplex today announced that it will showcase its complete, fully integrated Zapflex platform for the first time at the 2026 NAB Show, introducing powerful new ...
18/03/2026
THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE ...
18/03/2026
COW Jobs: Seeking DP for Low Budget Dramedy - Chicago
Brie Clayton March 17, 2026
0 Comments
Seeking Director of Photography for Low Budget Dramedy Fe...
18/03/2026
COW Jobs: Seeking Gaffer for Low Budget Dramedy - Chicago
Brie Clayton March 17, 2026
0 Comments
Seeking Gaffer for Low Budget Dramedy Feature Film- I...
18/03/2026
COW Jobs: Seeking Location, Sound for Low Budget Dramedy - Chicago
Brie Clayton March 17, 2026
0 Comments
Seeking Location/Sound for Low Budget Dramed...
18/03/2026
COW Jobs: Seeking Child Wrangler for Low Budget Film - Chicago
Brie Clayton March 17, 2026
0 Comments
Seeking Child Wrangler for Low Budget Dramedy Fe...
18/03/2026
Calrec Redefines Broadcast Workflows at NAB 2026 with its Most Powerful Hardware...
18/03/2026
Oscar Nominated Two People Exchanging Saliva Posted with DaVinci Resolve Studio
Brie Clayton March 17, 2026
0 Comments
DaVinci Resolve Studio handle...
18/03/2026
Boston Conservatory Presents Celebrated Musical Satire Urinetown Performances for this Center Stage production will take place at Boston Conservatory Theater ...
18/03/2026
Charlie Puth Joins Switched on Pop at Berklee NYC The Berklee alum spoke with host and Berklee NYC professor Charlie Harding for a live taping, answering audi...
18/03/2026
X-Rite Pantone Demonstrates Advanced Color Management Solutions to Support Smart...
18/03/2026
Wednesday 18 March 2026
BAFTA winner James McAvoy to star in Sky Original serie...
18/03/2026
Wednesday 18 March 2026
Sky Sports and Zuffa Boxing announce multi-year agreement for the UK and Ireland
Sky Sports and Zuffa Boxing have announced a new mult...
18/03/2026
Wednesday 18 March 2026
Sky Unveils Poster and Trailer for Original Feature Fil...
Team Finds a Better Way to Engineer Therapeutic Proteins into Antibodies Scripps Research and Rockefeller Scientists Work on Obesity Therapy as Proof-of-Principle
